Aligned Genetics (238120) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Aligned Genetics (238120) reported revenue of 16.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202516.0 billion KRW2.4 billion KRW2.9 billion KRW[source]
202415.8 billion KRW2.8 billion KRW4.1 billion KRW[source]
202315.2 billion KRW3.3 billion KRW3.2 billion KRW[source]
202213.8 billion KRW2.8 billion KRW2.3 billion KRW[source]
202111.8 billion KRW2.2 billion KRW5.5 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202556.7 billion KRW20.1 billion KRW36.6 billion KRW[source]
202443.5 billion KRW8.5 billion KRW35.0 billion KRW[source]
202340.8 billion KRW9.4 billion KRW31.4 billion KRW[source]
202236.9 billion KRW7.8 billion KRW29.1 billion KRW[source]
202134.7 billion KRW7.4 billion KRW27.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice